9 Biometric Screening Metrics Every Wellness Program Tracks

Most wellness directors inherit a screening panel without ever auditing what each number actually predicts. The annual event produces a stack of reports, a participation percentage for the incentive file, and a vague sense that the organization is doing something about health risk. Yet the value of a screening lives entirely in the biometric screening metrics it captures and how well those markers map to the chronic conditions driving an employer's medical spend. Understanding what biometric screening measures, and why each number earns its place on the panel, separates a program that moves risk from one that simply documents it.

The case for getting this right is not abstract. Chronic disease now accounts for 90 percent of the nation's $5.3 trillion in annual healthcare expenditures, according to the U.S. Centers for Disease Control and Prevention (2024). The markers a screening captures are the earliest, cheapest signals that a population is drifting toward those costs.

Nearly half of U.S. adults, roughly 119.9 million people, have high blood pressure, and an estimated 115.2 million adults have prediabetes, with about 8 in 10 unaware they have it. Source: CDC High Blood Pressure Facts and National Diabetes Statistics Report (2024).

What biometric screening metrics actually measure

A biometric screening is a structured snapshot of physiological risk. The core panel has stayed remarkably stable for two decades because the same handful of markers carries the most predictive weight for cardiovascular disease, type 2 diabetes, and metabolic syndrome. The nine metrics below form the backbone of nearly every employer program, whether collected by onsite nurses, at a lab, or through newer digital methods.

These employee health screening numbers fall into three groups: cardiovascular markers (blood pressure, resting heart rate), metabolic markers (glucose, A1C, lipid panel), and body composition markers (BMI, waist circumference). Each tells a different part of the same story.

Metric	What it measures	Typical healthy range	Primary risk flagged
Blood pressure	Force of blood against artery walls (systolic/diastolic)	Below 120/80 mmHg	Hypertension, stroke, heart disease
Total cholesterol	Sum of all cholesterol in the blood	Below 200 mg/dL	Cardiovascular disease
HDL cholesterol	"Protective" cholesterol	40 mg/dL or higher	Low HDL raises heart risk
LDL cholesterol	"Harmful" cholesterol	Below 100 mg/dL	Plaque buildup, heart attack
Triglycerides	Fat circulating in blood	Below 150 mg/dL	Metabolic syndrome
Fasting glucose	Blood sugar after fasting	70 to 99 mg/dL	Prediabetes, type 2 diabetes
Hemoglobin A1C	Average blood sugar over ~3 months	Below 5.7 percent	Diabetes progression
Body Mass Index (BMI)	Weight relative to height	18.5 to 24.9	Obesity-linked conditions
Resting heart rate	Beats per minute at rest	60 to 100 bpm	Cardiovascular risk, low fitness

The cardiovascular markers

• Blood pressure is the single most actionable marker on the panel because hypertension is common, silent, and treatable. With hypertension prevalence at 47.7 percent of U.S. adults during 2021 to 2023 (CDC, 2024), a screening will surface elevated readings in roughly one of every two participants.
• Resting heart rate has earned a permanent place on modern panels. Research summarized from large cohort studies shows that adults with a resting heart rate above 80 bpm carry greater risk for both cardiovascular disease and all-cause mortality than those below 60 bpm, and that rising heart rate trends over time independently predict future heart failure.

The metabolic markers

• Fasting glucose and A1C work together. A single fasting glucose reading captures a moment; A1C reflects roughly three months of average blood sugar, which is why it has become the preferred marker for catching the prediabetic drift most employees never notice.
• The lipid panel (total, HDL, LDL, triglycerides) is rarely a single number. Reading the ratio between HDL and LDL tells a wellness team far more than total cholesterol alone.

The body composition markers

• BMI remains the most debated metric on the panel. It is cheap and fast but does not distinguish muscle from fat, which is why many programs now pair it with waist circumference for a fuller metabolic picture.

Why these wellness program health data points matter together

No single biometric screening metric tells the whole story. The reason these nine travel together is that they cluster. An employee with elevated fasting glucose often shows elevated triglycerides, low HDL, a higher BMI, and creeping blood pressure. That cluster has a name, metabolic syndrome, and it is the strongest population-level predictor of future claims an employer can capture without a physician visit.

For a wellness director, the practical value is segmentation. Aggregate, de-identified wellness program health data lets a benefits team see how much of the population sits in a borderline range that responds well to coaching versus how many have already crossed a clinical threshold. That distinction determines where program dollars produce return.

The markers also function as an early-warning system for the conditions that dominate employer spend. With 11 million U.S. adults carrying undiagnosed diabetes and over 27 percent of all diabetes cases undetected (CDC, 2024), a glucose or A1C reading at a screening is frequently the first time an employee learns they are at risk. That early flag is the entire economic argument for screening.

Industry Applications

Risk stratification for self-insured employers

Self-insured organizations use aggregate biometric data to model where claims are likely to originate. A population with a high share of borderline blood pressure and prediabetic glucose readings is a candidate for targeted hypertension and diabetes-prevention programming rather than broad, low-yield wellness spend.

Incentive and surcharge design

Many programs tie a portion of premium contributions to participation in, or outcomes from, screening. The metrics chosen shape the design. Outcome-based incentives must navigate compliance carefully, which is why most modern programs reward participation and reasonable-alternative pathways rather than penalizing specific numbers.

Engagement and personalization

The richest application is feedback. When employees receive their own numbers in plain language with clear next steps, the screening shifts from a compliance task to a personal health moment. The metrics become a conversation starter for coaching, condition management, and primary-care follow-up.

Current research and evidence

The evidence base behind these nine metrics is deep and still growing. The CDC's National Center for Health Statistics (Data Brief No. 511, October 2024) documents diabetes and prediabetes prevalence that makes glucose and A1C screening defensible for almost any adult population. On the cardiovascular side, a meta-analysis published in the National Institutes of Health literature on resting heart rate and mortality confirms a graded relationship between higher resting heart rate and both cardiovascular and all-cause death, supporting its inclusion alongside blood pressure.

Researchers at Northwestern University have also identified that abnormal resting heart rate patterns tracked over more than two decades predict future heart failure independent of baseline readings, reinforcing the value of capturing the same metrics year over year rather than treating each screening as a one-off.

The honest caveat from the research community is that screening alone does not change outcomes. Capturing biometric screening metrics identifies risk; sustained improvement requires program design that connects those numbers to coaching, follow-up, and access to care. The metrics are the starting line, not the finish.

The future of biometric screening metrics

The panel itself is unlikely to change much, because the underlying biology has not. What is changing is collection. Traditional onsite events and lab draws limit participation to employees who can fast, travel, and take time during the workday, which structurally excludes deskless, remote, and hybrid workers. The next phase of employer screening is about capturing the same validated metrics through lower-friction channels so that the data reflects the whole workforce, not just the people who could make it to the conference room.

Expect three shifts: continuous or more frequent capture replacing the annual snapshot, tighter integration between screening data and downstream coaching or care navigation, and broader use of remote and smartphone-based collection to reach populations that historic events missed. The metrics stay constant. The access expands.

Frequently asked questions

What does a biometric screening measure?

A standard biometric screening measures blood pressure, a lipid panel (total, HDL, and LDL cholesterol plus triglycerides), fasting glucose, often hemoglobin A1C, body mass index, and increasingly resting heart rate. Together these markers flag cardiovascular disease, prediabetes and diabetes, and metabolic syndrome risk.

Which biometric screening metric matters most?

No single metric dominates because the markers cluster. That said, blood pressure is often considered the most actionable because hypertension is highly prevalent, silent, and responsive to treatment. Glucose and A1C carry similar weight given how many cases of prediabetes go undetected.

Can my employer see my individual screening numbers?

No. Individual results are protected under federal privacy rules, and employers receive only aggregate, de-identified data showing population-level trends. Personal numbers go to the employee and their care providers, not to managers or HR.

How often should employees complete biometric screening?

Most programs run annually, which aligns with benefits cycles. Research on markers like resting heart rate suggests that tracking the same metrics consistently over multiple years adds predictive value beyond any single reading.

Circadify is working on this access problem directly, building employer health assessment technology that captures core biometric screening metrics without the cost and exclusion of traditional onsite events. Wellness directors and benefits teams evaluating a more inclusive screening model can explore the approach through an enterprise wellness demo.